Science and the Media

Your May 10, 2004, editorial1 brought to mind an experience I had about 40 years ago when I was a graduate student in biochemistry at Penn State University. I got a call from a person in the Public Relations Office who wanted to interview me about my research. It was my first such request and I was delighted to meet with her and proud to tell about what I was doing: studying the biochemical basis of a rare inherited disease in chickens involving vitamin B2 (riboflavin) metabolism.I carefully exp

Written byWilliam Winter
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Your May 10, 2004, editorial1 brought to mind an experience I had about 40 years ago when I was a graduate student in biochemistry at Penn State University. I got a call from a person in the Public Relations Office who wanted to interview me about my research. It was my first such request and I was delighted to meet with her and proud to tell about what I was doing: studying the biochemical basis of a rare inherited disease in chickens involving vitamin B2 (riboflavin) metabolism.

I carefully explained the research but the woman kept pressing me to explain the "practical value". Finally, I responded by saying that this work would help us to better understand normal cell processes that may be altered in diseases like cancer. That seemed to satisfy her and she promised to send me a copy of her story.

A number of weeks went by ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies